Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Legend Biotech (LEGN) Operating Margin (2024 - 2025)

Historic Operating Margin for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to 15.96%.

  • Legend Biotech's Operating Margin rose 279600.0% to 15.96% in Q3 2025 from the same period last year, while for Sep 2025 it was 73.8%, marking a year-over-year increase of 159500.0%. This contributed to the annual value of 23412.57% for FY2024, which is 95085900.0% up from last year.
  • Latest data reveals that Legend Biotech reported Operating Margin of 15.96% as of Q3 2025, which was up 279600.0% from 132.48% recorded in Q2 2025.
  • Legend Biotech's Operating Margin's 5-year high stood at 596.51% during Q2 2022, with a 5-year trough of 97962.57% in Q1 2021.
  • Its 5-year average for Operating Margin is 4921.94%, with a median of 215.62% in 2024.
  • Per our database at Business Quant, Legend Biotech's Operating Margin tumbled by -984513400bps in 2021 and then surged by 982082500bps in 2022.
  • Quarter analysis of 5 years shows Legend Biotech's Operating Margin stood at 230.36% in 2021, then soared by 72bps to 395.35% in 2022, then crashed by -85bps to 57.62% in 2023, then increased by 28bps to 73.77% in 2024, then tumbled by -122bps to 15.96% in 2025.
  • Its Operating Margin stands at 15.96% for Q3 2025, versus 132.48% for Q2 2025 and 147.38% for Q1 2025.